While PDL1 expression has been mostly linked to a higher response rate in other tumors like NSCLC [23], findings from trials such as IMPower 133 suggest that PDL1 expression is not predictive of overall survival in SCLC patients receiving chemotherapy with an ICI [17]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.